Introduction: Locaregional treatments (LRTs) are used both to form a transplantation bridge in hepatocellular carcinoma and to downstage tumor phase in tumors that have exceeded the limits of transplantation. The aim of this study was to assess the relationship between controversial locaregional treatments, and post transplantation recurrence rate.

Materials and Methods: The patients who were diagnosed with hepatocellular cancer on cirrhosis basis and underwent liver transplantation were retrospectively evaluated in terms of HCC recurrence. Depending on the application of LRT before transplantation, the patients were divided into two groups as LRT+ and LRT-.

Results: In our center, 50 patients were retrospectively evaluated between January 2000 and May 2013. Seven of the patients were female and the other 43 patients were male. The mean age of the patients was 49.58±18.6. The mean follow-up period after transplantation was 120,81. 42 % of the patients had LRT at least once before transplantation. Nine patients (18 %), of which five of them were with LRT+ and four of them were with LRT-, had recurrence in 44,55 months. When Ki-square test was used, in patients with LRT+ and LRT-, post-transplantation recurrence rate was not different. (p=0,98).

Conclusions: In our patients, it was observed that LRTs that were applied before liver transplantation had no effect on the development of recurrence after transplantation.